These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1753578)

  • 21. [Location and expression of apo(a) and apoB in peripheral blood of patients with cardiovascular disease].
    Ao CH; Qi LT; Xiong ZW; Xue L; Zhao CY; Huo Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Jun; 40(3):245-50. PubMed ID: 18560450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Determination of the usefulness of selected biochemical parameters for assessing the advanced atheromatous changes in human coronary arteries].
    Bukowska H
    Ann Acad Med Stetin; 1998; 44():29-43. PubMed ID: 9857530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
    Tsimikas S; Brilakis ES; Miller ER; McConnell JP; Lennon RJ; Kornman KS; Witztum JL; Berger PB
    N Engl J Med; 2005 Jul; 353(1):46-57. PubMed ID: 16000355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.
    Sierra-Johnson J; Somers VK; Kuniyoshi FH; Garza CA; Isley WL; Gami AS; Lopez-Jimenez F
    Am J Cardiol; 2006 Nov; 98(10):1369-73. PubMed ID: 17134631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum levels of Apo-AI and B as markers of synthetic graft stenosis after bypass for peripheral artery disease].
    Guzmán-Lepe S; Anaya-Prado R
    Cir Cir; 2008; 76(3):225-33. PubMed ID: 18647556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conventional and non-conventional coronary risk factors in male premature coronary artery disease patients already having a low Framingham risk score.
    Koz C; Baysan O; Hasimi A; Cihan M; Uzun M; Yokusoglu M; Sag C; Isik E
    Acta Cardiol; 2008 Oct; 63(5):623-8. PubMed ID: 19014007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [An immunoenzyme method of determining apoprotein B and its diagnostic value in ischemic heart disease].
    Anisimova OIu; Preobrazhenskiĭ SN; Liakishev AA; Preobrazhenskiĭ DV; Samko AN
    Kardiologiia; 1987 Oct; 27(10):39-43. PubMed ID: 3320453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipoprotein (A) in patients with coronary atherosclerosis].
    Olofinskaia IE; Volkova EI; Susekov AV; Liakishev AA; Pokrovskiĭ SN
    Kardiologiia; 1991 Oct; 31(10):36-8. PubMed ID: 1836509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasma lipoproteins and apolipoproteins. Value of their determination in the detection of coronary atherosclerosis. Comparison with data supplied by coronarography].
    Fruchart JC; Bertrand M; Parra H; Gentilini JL; Boniface B; Boniface M
    Nouv Presse Med; 1982 Nov; 11(47):3491-4. PubMed ID: 6818524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Atherosclerosis of the coronary arteries and the blood group in the population of Lithuania].
    Stakishaĭtis DV; Ivashkiavichene LI; Narvilene AM
    Vrach Delo; 1991 Aug; (8):55-7. PubMed ID: 1949735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reference values of plasma apolipoproteins A-I and B, and association with nonlipid risk factors in the populations of two Canadian provinces: Quebec and Saskatchewan. Canadian Heart Health Surveys Research Group.
    Connelly PW; Poapst M; Davignon J; Lussier-Cacan S; Reeder B; Lessard R; Hegele RA; Csima A
    Can J Cardiol; 1999 Apr; 15(4):409-18. PubMed ID: 10322250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Selected new atherosclerosis risk factors and markers of fibrinolysis in children and adolescents with obesity, hypertension and diabetes].
    Głowińska B; Urban M; Koput A; Galar M
    Przegl Lek; 2003; 60(1):12-7. PubMed ID: 12884639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies.
    Thompson A; Danesh J
    J Intern Med; 2006 May; 259(5):481-92. PubMed ID: 16629854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coronary sclerosis risk factors in males with special reference to lipoproteins and apoproteins: establishing an index.
    Kawanishi M; Nakamoto A; Konemori G; Horiuchi I; Kajiyama G
    Hiroshima J Med Sci; 1990 Sep; 39(3):61-4. PubMed ID: 2283305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Serum lipids and apolipoproteins AI, B100, CI, CII, and CIII in 142 patients with coronary heart disease].
    Liu BW; Shao MZ; Yuan HJ; Wu ZF; Zhang ZH; Fu MD; Zhang RJ; Fan P
    Hua Xi Yi Ke Da Xue Xue Bao; 1989 Jun; 20(2):119-22. PubMed ID: 2512245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different VLDL apo B, and HDL apo AI and apo AII metabolism in two heterozygous carriers of unrelated mutations in the lipoprotein lipase gene.
    Pérez-Méndez O; Duhal N; Lacroix B; Bonte JP; Fruchart JC; Luc G
    Clin Chim Acta; 2006 Jun; 368(1-2):149-54. PubMed ID: 16487502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors behind the increase in cardiovascular mortality in Russia: apolipoprotein AI and B distribution in the Arkhangelsk study 2000.
    Averina M; Nilssen O; Brenn T; Brox J; Arkhipovsky VL; Kalinin AG
    Clin Chem; 2004 Feb; 50(2):346-54. PubMed ID: 14684620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms at the 5'-end of the apolipoprotein AI gene and severity of coronary artery disease.
    Wang XL; Liu SX; McCredie RM; Wilcken DE
    J Clin Invest; 1996 Jul; 98(2):372-7. PubMed ID: 8755647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasma apolipoproteins AI and B: reference values in the Isère population and determination of individual values].
    Foulon T; Laporte F; Payen N; Groslambert P
    Ann Biol Clin (Paris); 1998; 56(4):451-6. PubMed ID: 9754281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serum apolipoprotein B is superior to LDL-cholesterol level in predicting incident coronary disease among Turks].
    Onat A; Ozhan H; Can G; Hergenç G; Karabulut A; Albayrak S
    Anadolu Kardiyol Derg; 2007 Jun; 7(2):128-33. PubMed ID: 17513206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.